Weight gain in infants with Pierre Robin sequence
Josip Tomic1, Philipp Metzler1, Andre Alcon2
1Department of Oral and Maxillofacial Surgery, Medical University of Graz, Graz, Austria.
Insights
Infants with Pierre Robin Sequence (PRS) experienced significant weight gain using a modified palatal plate (MPP). This treatment also reduced the need for early airway surgery in these infants.
Area of Science:
- Craniofacial anomalies
- Pediatric surgery
- Neonatal care
Background:
- Pierre Robin Sequence (PRS) is characterized by micrognathia, glossoptosis, and airway obstruction.
- Failure to thrive (FTT) is a common complication in infants with PRS.
- Current management often involves surgical interventions to address airway issues.
Purpose of the Study:
- To evaluate the efficacy of the modified palatal plate (MPP) in promoting weight gain in infants with PRS.
- To assess the impact of MPP treatment on the need for surgical airway management.
Main Methods:
- Retrospective study of 14 infants with isolated and syndromic PRS treated with MPP.
- Primary outcome: infant weight gain over three months post-birth.
- Data collected: demographics, comorbidities, genetic testing, and surgical interventions.
Main Results:
- 86% of infants showed statistically significant weight gain (p < 0.001) within three months.
- Mean weight increased from 3147g to 4435g.
- No infants required mandibular distraction or tongue-lip adhesion for airway management; 21% needed tracheotomy.
Conclusions:
- MPP treatment leads to significant weight gain in PRS infants.
- MPP may reduce the need for early surgical airway interventions.
- Accelerated weight gain may influence timing of future surgical procedures.
Objective:
To determine weight gain during treatment with the modified palatal plate (MPP) in infants with isolated and syndromic Pierre Robin Sequence (PRS) suffering from micrognathia, upper airway obstruction (UAO), and failure to thrive (FTT), the authors conducted a retrospective study of infants treated with the MPP.
Methods:
The main outcome measure was infant weight (g) for up to three months after birth. Demographic and outcome data (associated syndromes, comorbidities, presence of cleft lip or palate, intubation attempts, tracheotomy and cleft repair) were collected.
Results:
14 children born January 2010 - December 2019 were included. The majority (86%) of infants showed highly significant weight gain (p < 0.001) within a 3-month period (mean pretreatment weight 3147 g with a SD of 425 g vs mean weight at three months 4435 g with a SD of 635 g). Syndromic PRS was found in 7% of infants. 43% of nonsyndromic PRS patients were found to have other congenital anomalies. Genetic testing showed normal karyotypes in 93% of infants and a microdeletion in 7% of infants. 21% of infants required tracheotomy, but no patients required mandibular distraction (MDO) or tongue-lip adhesion (TLA) to relieve UAO.
Conclusion:
PRS infants treated with the MPP showed highly significant weight gain within a 3-month period and did not require mandibular surgery for early airway management, but faster gain of weight might have implications for strategies to perform surgery at an earlier point in time.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
Obesity
Drug Dosing: Infants and Children
Drug Dosing: Obese Patients
Pharmacokinetics in Pediatric Patients: Drug Distribution
Signs of Puberty


